Patents Examined by Qiuwen Mi
  • Patent number: 11351110
    Abstract: Embodiments of the present application relates to cosmetic compositions and cosmetic products free or substantially free of synthetic silicones. The cosmetic composition comprises one or more plant extracts rich in natural silicon (e.g., a bamboo extract), a unique blend of fatty acid esters derived from plant sources and also saccharides derived from plants.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: June 7, 2022
    Inventor: Kirsten Elizabeth Thomas
  • Patent number: 11351150
    Abstract: Compositions for treating a sleep disorder or modifying or improving the sleep-wake cycle in a subject are disclosed herein. In some examples, the composition can comprise one or more sleep promoting active agents, one or more sleep quality active agents, one or more sleep recovery active agents, and optionally one or more next day active agents. The composition can provide an immediate burst release of the one or more sleep promoting active agents, a delayed burst or delayed sustained release of the one or more sleep quality active agents, a delayed burst or delayed sustained release of the one or more sleep recovery active agents, and a delayed burst or delayed sustained release of the one or more next day active agents. The composition can be provided as a daily oral uni-dosage form. Methods of making and using the compositions are also provided.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: June 7, 2022
    Assignee: NightWise, LLC
    Inventors: Danny Rinaldi, Scott Forsberg
  • Patent number: 11337916
    Abstract: A pulp and skin extract from dried, seed-free Myrciaria dubia fruit. The Myrciaria dubia fruit has a maturity of at least 70%, a soluble solids/acidity ratio between 2.5 and 3, and it is rich in organic acids. The extract is obtained by solid-liquid extraction in a hydro-polyalcohol solvent selected from a hydro-glycerol and/or hydro-gylcolic solvent under agitation or with ultrasound. The extract is an active agent in cosmetic compositions, which reduce the signs of skin fatigue.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: May 24, 2022
    Assignees: ISP INVESTMENTS LLC
    Inventors: Jean-Marie Botto, Christophe Capallere, Catherine Gondran, Isabelle Imbert, Sèbastien Garnier, Erell Le Borgne
  • Patent number: 11331357
    Abstract: This invention relates to the extraction of psychoactive compounds from organisms for use in medicine. Extraction is carried out with a strong acid or strong base to either promote or inhibit dephosphorylation. The extract in the slurry form is standardized with added excipient so that when it is dried the powdered composition has a specified total psychoactive alkaloid concentration, with a known ratio of phosphorylated to dephosphorylated psychoactive alkaloids.
    Type: Grant
    Filed: June 15, 2021
    Date of Patent: May 17, 2022
    Assignee: PSILO SCIENTIFIC LTD.
    Inventors: Benjamin Lightburn, Ryan Moss, Lisa Ranken
  • Patent number: 11331361
    Abstract: A hybrid herbal and drug composition includes an amount of Chinese herb about 0.01 to 5% by weight of the composition; an amount of animal-based matter about 0.01 to 5% by weight of the composition; an amount of vitamin about 0.01 to 5% by weight of the composition; an amount of mineral about 0.01 to 5% by weight of the composition; an amount of hormone about 0.01 to 5% by weight of the composition; an amount of factory produced product about 0.01 to 5% by weight of the composition; and an amount of the purified water about 70% to 99.94% by weight of the composition.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: May 17, 2022
    Inventor: Shui Yin Lo
  • Patent number: 11324793
    Abstract: This invention provides herbal compositions useful for increasing the therapeutic index of chemotherapeutic compounds. This invention also provides methods useful for improving the quality of life of an individual undergoing chemotherapy. Furthermore, this invention improves the treatment of disease by increasing the therapeutic index of chemotherapy drugs by administering the herbal composition PHY906 to a mammal undergoing such chemotherapy.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: May 10, 2022
    Assignee: YALE UNIVERSITY
    Inventors: Shwu-Huey Liu, Zaoli Jiang, Yung-Chi Cheng
  • Patent number: 11324245
    Abstract: The present invention relates to a beet juice with an increased intestinal absorption rate, a method for manufacturing the beet juice, and use of the same, and more specifically, to a beet juice with an intestinal digestion and absorption rate increased by transforming high-molecular compounds into low-molecular compounds by low-temperature ripening a beet, with the earthy flavor removed by baking the beet, and with the earthy and bitter taste mitigated by adding a carrot juice or apple juice, and an anti-oxidative, or anti-hypertensive, healthy food composition using the beet juice.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: May 10, 2022
    Inventor: Daisik Harm
  • Patent number: 11318171
    Abstract: Methods and egg yolk powder containing compositions for improving skeletal muscle protein fractional synthetic rate (FSR) in mammals and inhibiting or reversing sarcopenia are provided.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: May 3, 2022
    Assignee: MYOS CORP.
    Inventors: Joseph Mannello, Neerav D. Padliya, Maghsoud Dariani
  • Patent number: 11311593
    Abstract: Disclosed is a root extract from plants of the Morus genus (in particular Morus albaet, Morus nigra) that is rich in prenylated polyphenols chosen from: moracenin A, moracenin B, kuwanon C, wittiorumin F and mulberrofuran T, a method for preparing such an extract and a cosmetic composition and a pharmaceutical or nutraceutical composition, the compositions including, as the active ingredient, at least one root extract from plants of the Morus genus according to the invention.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: April 26, 2022
    Assignee: PLANT ADVANCED TECHNOLOGIES PAT
    Inventors: Léonor Cécile Duriot, Aleksander Bogusz Salwinski, Léa Iolé Heidi Rangoni
  • Patent number: 11304891
    Abstract: A process for the preparation of a plant extract enriched in polyphenols and/or substantially free of simple sugars, as well as the plant extract thus obtained, which may be added to a cosmetic composition. Also, the use of a yeast of the variety Saccharomyces cerevisiae var. bayanus for the removal of simple sugars in a plant extract.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: April 19, 2022
    Assignee: CHANEL PARFUMS BEAUTE
    Inventors: Alix Toribio, David Legangneux, Vincent Cocandeau
  • Patent number: 11298390
    Abstract: Disclosed is a total flavonoids extract of Gynura formosana Kitam., containing 80%-85% of rutin by weight percent content. The results of pharmacological experiments show that the extract can lower the activity of xanthine oxidase in the liver of a hyperuricemia model mouse and reduce the synthesis of uric acid to a certain degree and has a certain uric acid-lowering effect, and can be used as a potential drug for treating hyperuricemia or gout. The method for preparing the total flavonoids extract of Gynura formosana Kitam. comprises: after an extraction step, selecting a complex enzyme composed of enzymes with a specific composition and a specific ratio for enzymolosis, and further carrying out the step of extracting and concentrating with macroporous resin and isolating and purifying with macroporous resin, so that the HPLC purity of rutin in the resulting total flavonoids extract of Gynura formosana Kitam. reaches 80%-85%.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: April 12, 2022
    Assignee: Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.
    Inventors: Huijun Yuan, Tingting Yin, Fei Hong, Juan Yu, Jinxiang Zeng, Shicong Wang
  • Patent number: 11298393
    Abstract: A composition including a mixture of Trigonella foenum-graecum extract and bentonite. The mixture is applicable in several technological fields, including the pharmacological, cosmetic, and veterinary field. Notably, the composition is useful in the treatment of a viral infection. The composition is synergistic in the sense that the mixture of Trigonella foenum-graecum extract and bentonite has a higher efficiency than each of the components alone.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: April 12, 2022
    Inventor: Jens Steen Olsen
  • Patent number: 11298388
    Abstract: This invention relates to the extraction of psychoactive compounds from organisms for use in medicine. Extraction is carried out with a strong acid or strong base to either promote or inhibit dephosphorylation. The extract in the slurry form is standardized with added excipient so that when it is dried the powdered composition has a specified total psychoactive alkaloid concentration, with a known ratio of phosphorylated to dephosphorylated psychoactive alkaloids.
    Type: Grant
    Filed: September 23, 2021
    Date of Patent: April 12, 2022
    Assignee: PSILO SCIENTIFIC LTD.
    Inventors: Benjamin Lightburn, Ryan Moss, Lisa Ranken
  • Patent number: 11298387
    Abstract: The present disclosure relates to a bioavailable, oil composition wherein at least 20% by weight % of its total lipids content comprises polar lipids such as glycolipids or phospholipids, at least 30 weight % of its polar lipids comprises glycolipids, and no more than 4% by weight % of the oil composition is made up of chlorophyll species. Formulations containing and methods for producing said oil compositions from algal oils or extracts are also disclosed.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: April 12, 2022
    Assignee: Nooter/Eriksen, Inc.
    Inventors: Brian L. Goodall, Dmitry Kuklev, Glen L. Bostick
  • Patent number: 11291647
    Abstract: The present invention discloses process for preparation of a CO2 extract of Azadirachta indica and herbal compositions thereof for the treatment of Oral and Colon cancers. More particularly, the invention discloses a process for preparation of a standardized SCO2 extract of Azadirachta indica leaves and herbal compositions of the same for oral use.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: April 5, 2022
    Assignee: NISARGA BIOTECH PRIVATE LIMITED
    Inventor: Girish Sudhakar Soman
  • Patent number: 11291688
    Abstract: Methods are disclosed for reducing the proliferation of a tumor cell, increasing apoptosis of a tumor cell, and/or decreasing migration of a tumor cell. These methods include contacting the tumor cell with an effective amount of solubilized ECM or a soluble fraction of extracellular matrix (ECM), thereby reducing the proliferation of the tumor cell, increasing apoptosis of the tumor cell, and/or decreasing migration of the tumor cell. Methods are also disclosed for treating a subject with a tumor. The methods include administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising a soluble fraction of an ECM and a pharmaceutically acceptable carrier, thereby treating the tumor in the subject. In specific non-limiting examples, the tumor is a glioma and/or the ECM hydrogel is a urinary bladder ECM hydrogel.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: April 5, 2022
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Stephen Francis Badylak, George S. Hussey, Lindsey Tamiko Saldin, Mark Hikaru Murdock
  • Patent number: 11285090
    Abstract: According to the present invention there is provided a cosmetic composition comprising: (i) a salicylic acid compound; (ii) monoammonium glycyrrhizate; and (iii) a polyphenolic antioxidant agent.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: March 29, 2022
    Assignee: THE BOOTS COMPANY PLC
    Inventors: Leanne Marie James, Clare Helena O'Connor
  • Patent number: 11278484
    Abstract: The present invention relates to a non-therapeutic cosmetic method—for enhancing the overall quality of the skin and for treating aging skin which comprises the use of non-hydrolyzed nucleic acid material extracted from tuna containing more than 75% by weight of DNA salts and less than 1.5 wt % of proteins, and to a non-therapeutic cosmetic composition for topical application onto the skin comprising from 0.01 to 5.0% by weight of said non-hydrolyzed nucleic acid material in a cosmetic or pharmaceutical acceptable carrier.
    Type: Grant
    Filed: March 4, 2020
    Date of Patent: March 22, 2022
    Assignee: Kalichem SRL
    Inventors: Gianbattista Rastrelli, Francesco Rastrelli
  • Patent number: 11273105
    Abstract: A method for preparing stable liquid emulsion forms of plant extract is provided. A plant extract is mixed with a diluent oil as an oil mixture. Heat is applied to the oil mixture until the mixture reaches a threshold viscosity. An emulsifying agent is dispersed in water as an emulsifying solution. The oil mixture and emulsifying solution are mixed together. The mixed oil mixture and emulsifying solution are homogenized as a liquid form of the plant extract.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: March 15, 2022
    Assignee: Sorse Technology Corporation
    Inventors: Rodger Scott Riefler, Juan Jorge Ayala, Howard M. Lee
  • Patent number: 11266703
    Abstract: A process for producing a hemp powder with a preserved full spectrum nutritional complex from the whole plant. The process includes juicing fresh vegetation from the Cannabis sativa plant. The juiced product may be disposed in freezing vessels and flash-frozen at a temperature that preserves the molecular integrity of the molecular structure of the nutrients. In turn, the frozen juiced product may be freeze-dried to prepare a water-soluble powder that provides a synergistic entourage effect by preserving the full spectrum nutritional complex of the whole plant from which the powder is derived. In turn, the powder may be used in a variety of contexts.
    Type: Grant
    Filed: March 9, 2020
    Date of Patent: March 8, 2022
    Assignee: APAX OTC Business Development LLC
    Inventor: Sebastien Hebbelinck